Koers Tetra Bio-Pharma Inc. Toronto S.E.
Aandelen
TBP
CA88166Y1007
Farmaceutische producten
Omzet 2020 | - | Omzet 2021 | - | Marktkapitalisatie | 88,81 mln. 121 mln. 81,76 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | -26 mln. -35,47 mln. -23,94 mln. | Nettowinst (verlies) 2021 | -52 mln. -70,95 mln. -47,88 mln. | EV/omzet 2020 | - |
Nettoliquiditeiten 2020 | 501K 683K 461K | Nettoliquiditeiten 2021 | 1,77 mln. 2,42 mln. 1,63 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-1,86
x | K/w-verhouding 2021 |
-1,7
x | Werknemers | 33 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 99,01% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Natalie Leroux
IRC | Investor Relations Contact | - | - |
Michael Olders
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Guy Chamberland
CEO | Chief Executive Officer | - | 01-06-16 |
Catherine Auld
BRD | Director/Board Member | - | 28-05-21 |
H. Norton
CHM | Chairman | 63 | 17-09-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+42,07% | 6,28 mld. | |
-21,20% | 4,25 mld. | |
+5,38% | 3,36 mld. | |
-16,98% | 2,96 mld. | |
-5,82% | 2,45 mld. | |
+45,47% | 1,97 mld. | |
-12,67% | 1,61 mld. | |
-3,91% | 1,6 mld. | |
+44,56% | 1,51 mld. |